Anyone following DVAX??....Stock is moving higher on speculation FDA may lift clinical hold on Hepsilav.....Mkt cap is ridiculously low given their cash position...funded partnerships.. and pipeline... I think it has a far superior risk/reward profile than many of the stocks bandied about here.....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.